Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Jan;76(1):518-20.
doi: 10.1073/pnas.76.1.518.

Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice

Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice

R Walter et al. Proc Natl Acad Sci U S A. 1979 Jan.

Abstract

Pro-Leu-Gly-NH2 (MIF) and several structural analogues, all injected in 50-microgram doses daily in mice receiving morphine chronically, were found to prevent development of physical dependence as measured by changes in body temperature associated with naloxone-induced withdrawal. Dose-response studies, using again a protocol of daily injections of peptide at 50, 5, 0.5, 0.05, 0.005 microgram per mouse revealed MIF and cyclo(Leu-Gly) to be the most potent peptides and to be effective in blocking physical dependence to morphine at a dose as low as 0.5 and 0.05 microgram per mouse, respectively. The benzyloxycarbonyl derivative of MIF, Pro-Leu, and Pro- -Leu exhibited significant activities down to a dose of 5 microgram of peptide per mouse.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Psychopharmacology (Berl). 1977 Mar 23;52(1):55-62 - PubMed
    1. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4573-6 - PubMed
    1. Pharmacol Biochem Behav. 1978 Jan;8(1):7-11 - PubMed
    1. Brain Res. 1977 Sep 23;134(1):139-44 - PubMed
    1. Eur J Pharmacol. 1977 Jul 1;44(1):25-33 - PubMed

Publication types

LinkOut - more resources